Dr. Didier Zurwerra - MBA

•Product Manager Immunology •Responsible for launching the first-in-class biological immunomodulator (anti IL-4/13) for the treatment of atopic dermatitis in Switzerland

Prelauch/launch of dupilumab (atopic dermatitis, respiratory) and sarilumab (rheumatoid arthritis)

•Sales and business relationship management for an oncology portfolio in solid tumors (prostate cancer & CRC) in German-speaking part of Switzerland according to brand plan •Management of key HCP contacts

•Internal job change after 4 months due to profound reorganization •DRA Manager •Cross functional Project lead for the submission of a novel transdermal product for the treatment of Alzheimer’s disease to the Brasilian market in collaboration with customer (big Pharma) (since 09/2015) •Global project lead for strategic product outsourcing of Acino’s highest-selling/critical products from Switzerland to MENA region in exposure to executive committee

Postdoktorand, eigenständige Planung und Durchführung von innovativen Projektien für den Agrchemiemarkt. Arbeit im Team. Teilweise Projektleitung

Finance, Corporate Strategy, M&A, General Management

Finance, Corporate Strategy, M&A, General Management

Grundlagenforschung zur Entwicklung eines neuen Krebsmedikaments im spannenden Gebiet zwischen Chemie und Pharmakologie. Das Programm führe zu 5 Publikation incl. Science.

Spezialisierung in organischer und biologischer Chemie (proteomics, genomics und glycomics) 2 Stipendien für exzellente Leistungen in Chemie und Naturwissenschaften